Instrumento Inactivo

Acciones Celator Pharmaceuticals Inc

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	14/06/16
CELATOR PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Jazz Pharmaceuticals plc	02/06/16
Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal	31/05/16
Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ	31/05/16
Steve Cohen’s Point72 says it has perfect U.S. compliance	18/03/16

Directores	Puesto	Edad	Desde
Arthur C. Louie CTO	Chief Tech/Sci/R&D Officer	-	-

Sector

	Varia. 1 de ene.	Capi.
MODERNA, INC.	+33,37 %	49,46 mil M
IQVIA HOLDINGS INC.	+1,55 %	42,58 mil M
LONZA GROUP AG	+49,11 %	42,49 mil M
CELLTRION, INC.	-4,22 %	29,09 mil M
ICON PUBLIC LIMITED COMPANY	+11,57 %	26,61 mil M
ALNYLAM PHARMACEUTICALS, INC.	-21,00 %	18,64 mil M
BIO-TECHNE CORPORATION	+7,36 %	13,16 mil M
MEDPACE HOLDINGS, INC.	+28,30 %	12,55 mil M
UNITED THERAPEUTICS CORPORATION	+23,80 %	12,1 mil M